Predictors of the efficacy of vedolizumab in patients with ulcerative colitis. Article Swipe
Go Kajikawa
,
Tsunaki Sawada
,
Masanao Nakamura
,
Takeshi Yamamura
,
Keiko Maeda
,
Eri Ishikawa
,
Kota Uetsuki
,
Takashi Hirose
,
Tadashi Iida
,
Yasuyuki Mizutani
,
Kentaro Yamao
,
Takuya Ishikawa
,
Kazuhiro Furukawa
,
Hiroki Kawashima
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.18999/nagjms.86.3.407
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.18999/nagjms.86.3.407
Vedolizumab is a treatment option for ulcerative colitis but data on predictors of treatment response remain insufficient to establish personalized treatment strategies. We aimed to investigate the real-world effectiveness of vedolizumab in adult patients with ulcerative colitis and explore factors involved in predicting treatment response. This single-center, single-arm, prospective observational study included 26 patients with clinically active ulcerative colitis patients' characteristics at baseline, epidemiological information, existing treatment, clinical activity index score, endoscopic score, and blood test data were collected. Serum levels of tumor necrosis factors alpha, interferon gamma, interleukin-4, interleukin-6, interleukin-10, interleukin-17, soluble mucosal addressin cell adhesion molecule 1, and soluble vascular cell adhesion molecule 1 were measured. Patient characteristics in the remission and non-remission groups were compared based on these parameters. Clinical remission at 6 weeks of treatment occurred in 9 (35%) of the 26 patients. At 14 weeks, clinical remission was observed in 11 patients (42%). There were no significant differences pertaining to age, sex, duration of disease, extent of disease, steroid resistance, or prior treatment with biological agents among the two groups after 14 weeks of treatment. Hemoglobin ≥ 11.5 g/dL (odds ratio, 15.0; 95% confidence interval, 1.50-149; P=0.014) and soluble mucosal addressin cell adhesion molecule 1 ≥ 765 pg/mL (odds ratio, 17.3; 95% confidence interval, 2.36-127; P=0.004) were significant factors. In conclusion, hemoglobin and serum soluble mucosal addressin cell adhesion molecule 1 levels are factors correlated with the therapeutic efficacy of vedolizumab.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://pubmed.ncbi.nlm.nih.gov/39355361
- OA Status
- green
- Cited By
- 1
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4403084516
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4403084516Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.18999/nagjms.86.3.407Digital Object Identifier
- Title
-
Predictors of the efficacy of vedolizumab in patients with ulcerative colitis.Work title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-08-01Full publication date if available
- Authors
-
Go Kajikawa, Tsunaki Sawada, Masanao Nakamura, Takeshi Yamamura, Keiko Maeda, Eri Ishikawa, Kota Uetsuki, Takashi Hirose, Tadashi Iida, Yasuyuki Mizutani, Kentaro Yamao, Takuya Ishikawa, Kazuhiro Furukawa, Hiroki KawashimaList of authors in order
- Landing page
-
https://pubmed.ncbi.nlm.nih.gov/39355361Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.ncbi.nlm.nih.gov/pmc/articles/11439607Direct OA link when available
- Concepts
-
Vedolizumab, Ulcerative colitis, Medicine, Internal medicine, Gastroenterology, DiseaseTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1Per-year citation counts (last 5 years)
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4403084516 |
|---|---|
| doi | https://doi.org/10.18999/nagjms.86.3.407 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/39355361 |
| ids.openalex | https://openalex.org/W4403084516 |
| fwci | 0.92155311 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000188 |
| mesh[1].descriptor_ui | D003093 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | drug therapy |
| mesh[1].descriptor_name | Colitis, Ulcerative |
| mesh[2].qualifier_ui | Q000097 |
| mesh[2].descriptor_ui | D003093 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | blood |
| mesh[2].descriptor_name | Colitis, Ulcerative |
| mesh[3].qualifier_ui | Q000627 |
| mesh[3].descriptor_ui | D061067 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | therapeutic use |
| mesh[3].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D008297 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Male |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D005260 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Female |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D000328 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Adult |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D008875 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Middle Aged |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D011446 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Prospective Studies |
| mesh[9].qualifier_ui | Q000627 |
| mesh[9].descriptor_ui | D005765 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | therapeutic use |
| mesh[9].descriptor_name | Gastrointestinal Agents |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D016896 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Treatment Outcome |
| mesh[11].qualifier_ui | Q000097 |
| mesh[11].descriptor_ui | D019010 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | blood |
| mesh[11].descriptor_name | Vascular Cell Adhesion Molecule-1 |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D012074 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Remission Induction |
| mesh[13].qualifier_ui | Q000097 |
| mesh[13].descriptor_ui | D009088 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | blood |
| mesh[13].descriptor_name | Mucoproteins |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D000368 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Aged |
| mesh[15].qualifier_ui | Q000097 |
| mesh[15].descriptor_ui | D015815 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | blood |
| mesh[15].descriptor_name | Cell Adhesion Molecules |
| mesh[16].qualifier_ui | Q000097 |
| mesh[16].descriptor_ui | D015703 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | blood |
| mesh[16].descriptor_name | Antigens, CD |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D006801 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Humans |
| mesh[18].qualifier_ui | Q000188 |
| mesh[18].descriptor_ui | D003093 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | drug therapy |
| mesh[18].descriptor_name | Colitis, Ulcerative |
| mesh[19].qualifier_ui | Q000097 |
| mesh[19].descriptor_ui | D003093 |
| mesh[19].is_major_topic | True |
| mesh[19].qualifier_name | blood |
| mesh[19].descriptor_name | Colitis, Ulcerative |
| mesh[20].qualifier_ui | Q000627 |
| mesh[20].descriptor_ui | D061067 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | therapeutic use |
| mesh[20].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D008297 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Male |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D005260 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Female |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D000328 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Adult |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D008875 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Middle Aged |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D011446 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Prospective Studies |
| mesh[26].qualifier_ui | Q000627 |
| mesh[26].descriptor_ui | D005765 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | therapeutic use |
| mesh[26].descriptor_name | Gastrointestinal Agents |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D016896 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Treatment Outcome |
| mesh[28].qualifier_ui | Q000097 |
| mesh[28].descriptor_ui | D019010 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | blood |
| mesh[28].descriptor_name | Vascular Cell Adhesion Molecule-1 |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D012074 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Remission Induction |
| mesh[30].qualifier_ui | Q000097 |
| mesh[30].descriptor_ui | D009088 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | blood |
| mesh[30].descriptor_name | Mucoproteins |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D000368 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Aged |
| mesh[32].qualifier_ui | Q000097 |
| mesh[32].descriptor_ui | D015815 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | blood |
| mesh[32].descriptor_name | Cell Adhesion Molecules |
| mesh[33].qualifier_ui | Q000097 |
| mesh[33].descriptor_ui | D015703 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | blood |
| mesh[33].descriptor_name | Antigens, CD |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D006801 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Humans |
| mesh[35].qualifier_ui | Q000188 |
| mesh[35].descriptor_ui | D003093 |
| mesh[35].is_major_topic | True |
| mesh[35].qualifier_name | drug therapy |
| mesh[35].descriptor_name | Colitis, Ulcerative |
| mesh[36].qualifier_ui | Q000097 |
| mesh[36].descriptor_ui | D003093 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | blood |
| mesh[36].descriptor_name | Colitis, Ulcerative |
| mesh[37].qualifier_ui | Q000627 |
| mesh[37].descriptor_ui | D061067 |
| mesh[37].is_major_topic | True |
| mesh[37].qualifier_name | therapeutic use |
| mesh[37].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D008297 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Male |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D005260 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Female |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D000328 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Adult |
| mesh[41].qualifier_ui | |
| mesh[41].descriptor_ui | D008875 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | |
| mesh[41].descriptor_name | Middle Aged |
| mesh[42].qualifier_ui | |
| mesh[42].descriptor_ui | D011446 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | |
| mesh[42].descriptor_name | Prospective Studies |
| mesh[43].qualifier_ui | Q000627 |
| mesh[43].descriptor_ui | D005765 |
| mesh[43].is_major_topic | True |
| mesh[43].qualifier_name | therapeutic use |
| mesh[43].descriptor_name | Gastrointestinal Agents |
| mesh[44].qualifier_ui | |
| mesh[44].descriptor_ui | D016896 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | |
| mesh[44].descriptor_name | Treatment Outcome |
| mesh[45].qualifier_ui | Q000097 |
| mesh[45].descriptor_ui | D019010 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | blood |
| mesh[45].descriptor_name | Vascular Cell Adhesion Molecule-1 |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D012074 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Remission Induction |
| mesh[47].qualifier_ui | Q000097 |
| mesh[47].descriptor_ui | D009088 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | blood |
| mesh[47].descriptor_name | Mucoproteins |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D000368 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | Aged |
| mesh[49].qualifier_ui | Q000097 |
| mesh[49].descriptor_ui | D015815 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | blood |
| mesh[49].descriptor_name | Cell Adhesion Molecules |
| type | article |
| title | Predictors of the efficacy of vedolizumab in patients with ulcerative colitis. |
| biblio.issue | 3 |
| biblio.volume | 86 |
| biblio.last_page | 421 |
| biblio.first_page | 407 |
| topics[0].id | https://openalex.org/T13569 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9962000250816345 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2713 |
| topics[0].subfield.display_name | Epidemiology |
| topics[0].display_name | Microscopic Colitis |
| topics[1].id | https://openalex.org/T10134 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9948999881744385 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1311 |
| topics[1].subfield.display_name | Genetics |
| topics[1].display_name | Inflammatory Bowel Disease |
| topics[2].id | https://openalex.org/T11834 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9781000018119812 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2721 |
| topics[2].subfield.display_name | Hepatology |
| topics[2].display_name | Liver Diseases and Immunity |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2776207728 |
| concepts[0].level | 4 |
| concepts[0].score | 0.9922127723693848 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q7918002 |
| concepts[0].display_name | Vedolizumab |
| concepts[1].id | https://openalex.org/C2780479503 |
| concepts[1].level | 3 |
| concepts[1].score | 0.8912572264671326 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1477 |
| concepts[1].display_name | Ulcerative colitis |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.6187547445297241 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C126322002 |
| concepts[3].level | 1 |
| concepts[3].score | 0.5064748525619507 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[3].display_name | Internal medicine |
| concepts[4].id | https://openalex.org/C90924648 |
| concepts[4].level | 1 |
| concepts[4].score | 0.39672601222991943 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q120569 |
| concepts[4].display_name | Gastroenterology |
| concepts[5].id | https://openalex.org/C2779134260 |
| concepts[5].level | 2 |
| concepts[5].score | 0.11435171961784363 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[5].display_name | Disease |
| keywords[0].id | https://openalex.org/keywords/vedolizumab |
| keywords[0].score | 0.9922127723693848 |
| keywords[0].display_name | Vedolizumab |
| keywords[1].id | https://openalex.org/keywords/ulcerative-colitis |
| keywords[1].score | 0.8912572264671326 |
| keywords[1].display_name | Ulcerative colitis |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.6187547445297241 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/internal-medicine |
| keywords[3].score | 0.5064748525619507 |
| keywords[3].display_name | Internal medicine |
| keywords[4].id | https://openalex.org/keywords/gastroenterology |
| keywords[4].score | 0.39672601222991943 |
| keywords[4].display_name | Gastroenterology |
| keywords[5].id | https://openalex.org/keywords/disease |
| keywords[5].score | 0.11435171961784363 |
| keywords[5].display_name | Disease |
| language | en |
| locations[0].id | pmid:39355361 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S4306525036 |
| locations[0].source.issn | |
| locations[0].source.type | repository |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | PubMed |
| locations[0].source.host_organization | https://openalex.org/I1299303238 |
| locations[0].source.host_organization_name | National Institutes of Health |
| locations[0].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Nagoya journal of medical science |
| locations[0].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/39355361 |
| locations[1].id | pmh:oai:pubmedcentral.nih.gov:11439607 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S2764455111 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed Central |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | other-oa |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/other-oa |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | Nagoya J Med Sci |
| locations[1].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11439607 |
| indexed_in | pubmed |
| authorships[0].author.id | https://openalex.org/A5028358943 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Go Kajikawa |
| authorships[0].countries | JP |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I60134161 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. |
| authorships[0].institutions[0].id | https://openalex.org/I60134161 |
| authorships[0].institutions[0].ror | https://ror.org/04chrp450 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I60134161 |
| authorships[0].institutions[0].country_code | JP |
| authorships[0].institutions[0].display_name | Nagoya University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Go Kajikawa |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. |
| authorships[1].author.id | https://openalex.org/A5009069198 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-4779-9708 |
| authorships[1].author.display_name | Tsunaki Sawada |
| authorships[1].countries | JP |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210090647 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Endoscopy, Nagoya University Hospital, Nagoya, Japan. |
| authorships[1].institutions[0].id | https://openalex.org/I4210090647 |
| authorships[1].institutions[0].ror | https://ror.org/008zz8m46 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210090647 |
| authorships[1].institutions[0].country_code | JP |
| authorships[1].institutions[0].display_name | Nagoya University Hospital |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Tsunaki Sawada |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Endoscopy, Nagoya University Hospital, Nagoya, Japan. |
| authorships[2].author.id | https://openalex.org/A5051339038 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-5444-143X |
| authorships[2].author.display_name | Masanao Nakamura |
| authorships[2].countries | JP |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210090647 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Endoscopy, Nagoya University Hospital, Nagoya, Japan. |
| authorships[2].institutions[0].id | https://openalex.org/I4210090647 |
| authorships[2].institutions[0].ror | https://ror.org/008zz8m46 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210090647 |
| authorships[2].institutions[0].country_code | JP |
| authorships[2].institutions[0].display_name | Nagoya University Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Masanao Nakamura |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Endoscopy, Nagoya University Hospital, Nagoya, Japan. |
| authorships[3].author.id | https://openalex.org/A5023038231 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-4994-016X |
| authorships[3].author.display_name | Takeshi Yamamura |
| authorships[3].countries | JP |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I60134161 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. |
| authorships[3].institutions[0].id | https://openalex.org/I60134161 |
| authorships[3].institutions[0].ror | https://ror.org/04chrp450 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I60134161 |
| authorships[3].institutions[0].country_code | JP |
| authorships[3].institutions[0].display_name | Nagoya University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Takeshi Yamamura |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. |
| authorships[4].author.id | https://openalex.org/A5102419194 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Keiko Maeda |
| authorships[4].countries | JP |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I60134161 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. |
| authorships[4].institutions[0].id | https://openalex.org/I60134161 |
| authorships[4].institutions[0].ror | https://ror.org/04chrp450 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I60134161 |
| authorships[4].institutions[0].country_code | JP |
| authorships[4].institutions[0].display_name | Nagoya University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Keiko Maeda |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. |
| authorships[5].author.id | https://openalex.org/A5071636090 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-1623-7996 |
| authorships[5].author.display_name | Eri Ishikawa |
| authorships[5].countries | JP |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I60134161 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. |
| authorships[5].institutions[0].id | https://openalex.org/I60134161 |
| authorships[5].institutions[0].ror | https://ror.org/04chrp450 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I60134161 |
| authorships[5].institutions[0].country_code | JP |
| authorships[5].institutions[0].display_name | Nagoya University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Eri Ishikawa |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. |
| authorships[6].author.id | https://openalex.org/A5091453171 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Kota Uetsuki |
| authorships[6].countries | JP |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I60134161 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. |
| authorships[6].institutions[0].id | https://openalex.org/I60134161 |
| authorships[6].institutions[0].ror | https://ror.org/04chrp450 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I60134161 |
| authorships[6].institutions[0].country_code | JP |
| authorships[6].institutions[0].display_name | Nagoya University |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Kota Uetsuki |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. |
| authorships[7].author.id | https://openalex.org/A5000850367 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-3713-3072 |
| authorships[7].author.display_name | Takashi Hirose |
| authorships[7].countries | JP |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210090647 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Endoscopy, Nagoya University Hospital, Nagoya, Japan. |
| authorships[7].institutions[0].id | https://openalex.org/I4210090647 |
| authorships[7].institutions[0].ror | https://ror.org/008zz8m46 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210090647 |
| authorships[7].institutions[0].country_code | JP |
| authorships[7].institutions[0].display_name | Nagoya University Hospital |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Takashi Hirose |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Endoscopy, Nagoya University Hospital, Nagoya, Japan. |
| authorships[8].author.id | https://openalex.org/A5048443511 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-5491-6012 |
| authorships[8].author.display_name | Tadashi Iida |
| authorships[8].countries | JP |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I60134161 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. |
| authorships[8].institutions[0].id | https://openalex.org/I60134161 |
| authorships[8].institutions[0].ror | https://ror.org/04chrp450 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I60134161 |
| authorships[8].institutions[0].country_code | JP |
| authorships[8].institutions[0].display_name | Nagoya University |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Tadashi Iida |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. |
| authorships[9].author.id | https://openalex.org/A5067050108 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-4363-3161 |
| authorships[9].author.display_name | Yasuyuki Mizutani |
| authorships[9].countries | JP |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I60134161 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. |
| authorships[9].institutions[0].id | https://openalex.org/I60134161 |
| authorships[9].institutions[0].ror | https://ror.org/04chrp450 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I60134161 |
| authorships[9].institutions[0].country_code | JP |
| authorships[9].institutions[0].display_name | Nagoya University |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Yasuyuki Mizutani |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. |
| authorships[10].author.id | https://openalex.org/A5041123163 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-2497-7740 |
| authorships[10].author.display_name | Kentaro Yamao |
| authorships[10].countries | JP |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210090647 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Endoscopy, Nagoya University Hospital, Nagoya, Japan. |
| authorships[10].institutions[0].id | https://openalex.org/I4210090647 |
| authorships[10].institutions[0].ror | https://ror.org/008zz8m46 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210090647 |
| authorships[10].institutions[0].country_code | JP |
| authorships[10].institutions[0].display_name | Nagoya University Hospital |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Kentaro Yamao |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Endoscopy, Nagoya University Hospital, Nagoya, Japan. |
| authorships[11].author.id | https://openalex.org/A5090551412 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-5814-3555 |
| authorships[11].author.display_name | Takuya Ishikawa |
| authorships[11].countries | JP |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I60134161 |
| authorships[11].affiliations[0].raw_affiliation_string | Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. |
| authorships[11].institutions[0].id | https://openalex.org/I60134161 |
| authorships[11].institutions[0].ror | https://ror.org/04chrp450 |
| authorships[11].institutions[0].type | education |
| authorships[11].institutions[0].lineage | https://openalex.org/I60134161 |
| authorships[11].institutions[0].country_code | JP |
| authorships[11].institutions[0].display_name | Nagoya University |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Takuya Ishikawa |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. |
| authorships[12].author.id | https://openalex.org/A5048247150 |
| authorships[12].author.orcid | https://orcid.org/0000-0003-0980-9095 |
| authorships[12].author.display_name | Kazuhiro Furukawa |
| authorships[12].countries | JP |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I60134161 |
| authorships[12].affiliations[0].raw_affiliation_string | Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. |
| authorships[12].institutions[0].id | https://openalex.org/I60134161 |
| authorships[12].institutions[0].ror | https://ror.org/04chrp450 |
| authorships[12].institutions[0].type | education |
| authorships[12].institutions[0].lineage | https://openalex.org/I60134161 |
| authorships[12].institutions[0].country_code | JP |
| authorships[12].institutions[0].display_name | Nagoya University |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Kazuhiro Furukawa |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. |
| authorships[13].author.id | https://openalex.org/A5074762441 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-3720-781X |
| authorships[13].author.display_name | Hiroki Kawashima |
| authorships[13].countries | JP |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I60134161 |
| authorships[13].affiliations[0].raw_affiliation_string | Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. |
| authorships[13].institutions[0].id | https://openalex.org/I60134161 |
| authorships[13].institutions[0].ror | https://ror.org/04chrp450 |
| authorships[13].institutions[0].type | education |
| authorships[13].institutions[0].lineage | https://openalex.org/I60134161 |
| authorships[13].institutions[0].country_code | JP |
| authorships[13].institutions[0].display_name | Nagoya University |
| authorships[13].author_position | last |
| authorships[13].raw_author_name | Hiroki Kawashima |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11439607 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Predictors of the efficacy of vedolizumab in patients with ulcerative colitis. |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T13569 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9962000250816345 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2713 |
| primary_topic.subfield.display_name | Epidemiology |
| primary_topic.display_name | Microscopic Colitis |
| related_works | https://openalex.org/W2748952813, https://openalex.org/W2614800544, https://openalex.org/W2530401429, https://openalex.org/W4388825894, https://openalex.org/W3031052312, https://openalex.org/W4399443163, https://openalex.org/W2607430076, https://openalex.org/W2915530814, https://openalex.org/W2221971298, https://openalex.org/W3007087481 |
| cited_by_count | 1 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 2 |
| best_oa_location.id | pmh:oai:pubmedcentral.nih.gov:11439607 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764455111 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | PubMed Central |
| best_oa_location.source.host_organization | https://openalex.org/I1299303238 |
| best_oa_location.source.host_organization_name | National Institutes of Health |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| best_oa_location.license | other-oa |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Text |
| best_oa_location.license_id | https://openalex.org/licenses/other-oa |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | Nagoya J Med Sci |
| best_oa_location.landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11439607 |
| primary_location.id | pmid:39355361 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S4306525036 |
| primary_location.source.issn | |
| primary_location.source.type | repository |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | PubMed |
| primary_location.source.host_organization | https://openalex.org/I1299303238 |
| primary_location.source.host_organization_name | National Institutes of Health |
| primary_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Nagoya journal of medical science |
| primary_location.landing_page_url | https://pubmed.ncbi.nlm.nih.gov/39355361 |
| publication_date | 2024-08-01 |
| publication_year | 2024 |
| referenced_works_count | 0 |
| abstract_inverted_index.1 | 105, 199, 225 |
| abstract_inverted_index.6 | 125 |
| abstract_inverted_index.9 | 131 |
| abstract_inverted_index.a | 2 |
| abstract_inverted_index.1, | 98 |
| abstract_inverted_index.11 | 145 |
| abstract_inverted_index.14 | 138, 176 |
| abstract_inverted_index.26 | 52, 135 |
| abstract_inverted_index.At | 137 |
| abstract_inverted_index.In | 214 |
| abstract_inverted_index.We | 22 |
| abstract_inverted_index.at | 61, 124 |
| abstract_inverted_index.in | 31, 41, 110, 130, 144 |
| abstract_inverted_index.is | 1 |
| abstract_inverted_index.no | 150 |
| abstract_inverted_index.of | 12, 29, 81, 127, 133, 158, 161, 178, 234 |
| abstract_inverted_index.on | 10, 119 |
| abstract_inverted_index.or | 165 |
| abstract_inverted_index.to | 17, 24, 154 |
| abstract_inverted_index.765 | 201 |
| abstract_inverted_index.95% | 187, 206 |
| abstract_inverted_index.and | 37, 73, 99, 113, 192, 217 |
| abstract_inverted_index.are | 227 |
| abstract_inverted_index.but | 8 |
| abstract_inverted_index.for | 5 |
| abstract_inverted_index.the | 26, 111, 134, 172, 231 |
| abstract_inverted_index.two | 173 |
| abstract_inverted_index.was | 142 |
| abstract_inverted_index.≥ | 181, 200 |
| abstract_inverted_index.11.5 | 182 |
| abstract_inverted_index.This | 45 |
| abstract_inverted_index.age, | 155 |
| abstract_inverted_index.cell | 95, 102, 196, 222 |
| abstract_inverted_index.data | 9, 76 |
| abstract_inverted_index.g/dL | 183 |
| abstract_inverted_index.sex, | 156 |
| abstract_inverted_index.test | 75 |
| abstract_inverted_index.were | 77, 106, 116, 149, 211 |
| abstract_inverted_index.with | 34, 54, 168, 230 |
| abstract_inverted_index.(35%) | 132 |
| abstract_inverted_index.(odds | 184, 203 |
| abstract_inverted_index.15.0; | 186 |
| abstract_inverted_index.17.3; | 205 |
| abstract_inverted_index.Serum | 79 |
| abstract_inverted_index.There | 148 |
| abstract_inverted_index.adult | 32 |
| abstract_inverted_index.after | 175 |
| abstract_inverted_index.aimed | 23 |
| abstract_inverted_index.among | 171 |
| abstract_inverted_index.based | 118 |
| abstract_inverted_index.blood | 74 |
| abstract_inverted_index.index | 69 |
| abstract_inverted_index.pg/mL | 202 |
| abstract_inverted_index.prior | 166 |
| abstract_inverted_index.serum | 218 |
| abstract_inverted_index.study | 50 |
| abstract_inverted_index.these | 120 |
| abstract_inverted_index.tumor | 82 |
| abstract_inverted_index.weeks | 126, 177 |
| abstract_inverted_index.(42%). | 147 |
| abstract_inverted_index.active | 56 |
| abstract_inverted_index.agents | 170 |
| abstract_inverted_index.alpha, | 85 |
| abstract_inverted_index.extent | 160 |
| abstract_inverted_index.gamma, | 87 |
| abstract_inverted_index.groups | 115, 174 |
| abstract_inverted_index.levels | 80, 226 |
| abstract_inverted_index.option | 4 |
| abstract_inverted_index.ratio, | 185, 204 |
| abstract_inverted_index.remain | 15 |
| abstract_inverted_index.score, | 70, 72 |
| abstract_inverted_index.weeks, | 139 |
| abstract_inverted_index.Patient | 108 |
| abstract_inverted_index.colitis | 7, 36, 58 |
| abstract_inverted_index.explore | 38 |
| abstract_inverted_index.factors | 39, 84, 228 |
| abstract_inverted_index.mucosal | 93, 194, 220 |
| abstract_inverted_index.soluble | 92, 100, 193, 219 |
| abstract_inverted_index.steroid | 163 |
| abstract_inverted_index.Clinical | 122 |
| abstract_inverted_index.P=0.004) | 210 |
| abstract_inverted_index.P=0.014) | 191 |
| abstract_inverted_index.activity | 68 |
| abstract_inverted_index.adhesion | 96, 103, 197, 223 |
| abstract_inverted_index.clinical | 67, 140 |
| abstract_inverted_index.compared | 117 |
| abstract_inverted_index.disease, | 159, 162 |
| abstract_inverted_index.duration | 157 |
| abstract_inverted_index.efficacy | 233 |
| abstract_inverted_index.existing | 65 |
| abstract_inverted_index.factors. | 213 |
| abstract_inverted_index.included | 51 |
| abstract_inverted_index.involved | 40 |
| abstract_inverted_index.molecule | 97, 104, 198, 224 |
| abstract_inverted_index.necrosis | 83 |
| abstract_inverted_index.observed | 143 |
| abstract_inverted_index.occurred | 129 |
| abstract_inverted_index.patients | 33, 53, 146 |
| abstract_inverted_index.response | 14 |
| abstract_inverted_index.vascular | 101 |
| abstract_inverted_index.1.50-149; | 190 |
| abstract_inverted_index.2.36-127; | 209 |
| abstract_inverted_index.addressin | 94, 195, 221 |
| abstract_inverted_index.baseline, | 62 |
| abstract_inverted_index.establish | 18 |
| abstract_inverted_index.interval, | 189, 208 |
| abstract_inverted_index.measured. | 107 |
| abstract_inverted_index.patients' | 59 |
| abstract_inverted_index.patients. | 136 |
| abstract_inverted_index.remission | 112, 123, 141 |
| abstract_inverted_index.response. | 44 |
| abstract_inverted_index.treatment | 3, 13, 20, 43, 128, 167 |
| abstract_inverted_index.Hemoglobin | 180 |
| abstract_inverted_index.biological | 169 |
| abstract_inverted_index.clinically | 55 |
| abstract_inverted_index.collected. | 78 |
| abstract_inverted_index.confidence | 188, 207 |
| abstract_inverted_index.correlated | 229 |
| abstract_inverted_index.endoscopic | 71 |
| abstract_inverted_index.hemoglobin | 216 |
| abstract_inverted_index.interferon | 86 |
| abstract_inverted_index.pertaining | 153 |
| abstract_inverted_index.predicting | 42 |
| abstract_inverted_index.predictors | 11 |
| abstract_inverted_index.real-world | 27 |
| abstract_inverted_index.treatment, | 66 |
| abstract_inverted_index.treatment. | 179 |
| abstract_inverted_index.ulcerative | 6, 35, 57 |
| abstract_inverted_index.Vedolizumab | 0 |
| abstract_inverted_index.conclusion, | 215 |
| abstract_inverted_index.differences | 152 |
| abstract_inverted_index.investigate | 25 |
| abstract_inverted_index.parameters. | 121 |
| abstract_inverted_index.prospective | 48 |
| abstract_inverted_index.resistance, | 164 |
| abstract_inverted_index.significant | 151, 212 |
| abstract_inverted_index.single-arm, | 47 |
| abstract_inverted_index.strategies. | 21 |
| abstract_inverted_index.therapeutic | 232 |
| abstract_inverted_index.vedolizumab | 30 |
| abstract_inverted_index.information, | 64 |
| abstract_inverted_index.insufficient | 16 |
| abstract_inverted_index.personalized | 19 |
| abstract_inverted_index.vedolizumab. | 235 |
| abstract_inverted_index.effectiveness | 28 |
| abstract_inverted_index.non-remission | 114 |
| abstract_inverted_index.observational | 49 |
| abstract_inverted_index.interleukin-4, | 88 |
| abstract_inverted_index.interleukin-6, | 89 |
| abstract_inverted_index.single-center, | 46 |
| abstract_inverted_index.characteristics | 60, 109 |
| abstract_inverted_index.epidemiological | 63 |
| abstract_inverted_index.interleukin-10, | 90 |
| abstract_inverted_index.interleukin-17, | 91 |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 91 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 14 |
| citation_normalized_percentile.value | 0.70213108 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |